US Compounding Inc recalls Docusate Oral 10 mg/mL syringes due to microbial contamination
US Compounding Inc recalls Docusate Oral 10 mg/mL syringes (1mL, 2mL, 5mL) because of microbial contamination with B. cepacia. Affected products were sold nationwide with all lots.
Recall notice
Microbial Contamination of Non-Sterile Products; microbial contamination with B. cepacia
Contact the company
What happened, in plain English
US Compounding Inc is recalling Docusate Oral 10 mg/mL syringes (1mL, 2mL, and 5mL) due to microbial contamination with B. cepacia. This contamination could cause serious health risks if the product is used. Read more at govinfonow.com/recall/42538-us-compounding-inc-recalls-docusate-oral-10-mg-ml-syringes.
Source Summary by GovInfoNow · govinfonow.com/recall/42538-us-compounding-inc-recalls-docusate-oral-10-mg-ml-syringes · Updated October 9, 2026 · FDA enforcement record: FDA #D-0219-2017
Cite this page
“US Compounding Inc recalls Docusate Oral 10 mg/mL syringes due to microbial contamination.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42538-us-compounding-inc-recalls-docusate-oral-10-mg-ml-syringes. Based on FDA recall #D-0219-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0219-2017%22&limit=1).
Why it’s dangerous
The syringes were contaminated with B. cepacia, a type of bacteria that can cause infections. Using contaminated medication may lead to serious health issues, especially for individuals with weakened immune systems.
Who’s affected
People who have purchased or use Docusate Oral 10 mg/mL syringes from US Compounding Inc. Those with medical conditions requiring frequent use of this medication are at higher risk.
How to tell if you have this one
Check for syringes labeled as Docusate Oral 10 mg/mL with lot numbers 62295-0601-01 (1mL), 62295-0601-02 (2mL), or 62295-0601-05 (5mL). These products were sold nationwide with all lots.
- Brand
US Compounding Inc- Category
Drug
What to do — step by step
Check Product Label
Look for syringes labeled Docusate Oral 10 mg/mL with lot numbers 62295-0601-01, 62295-0601-02, or 62295-0601-05.
Where it went and when
Where it was distributed
Distributed in Texas.
FDA distribution: “TX” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Texas.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0219-2017 (July 25, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0219-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.